{
    "nct_id": "NCT06588283",
    "official_title": "Efficacy and Safety of Ixekizumab or Ixekizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight: A Phase 3b, Randomized, Multicenter, Open-Label Study (TOGETHER-PsO)",
    "inclusion_criteria": "* Have a diagnosis of moderate-to-severe plaque psoriasis (PsO) for at least 6 months.\n* Have both a Static Physician's Global Assessment (sPGA) score of ≥3 and a Psoriasis Area and Severity Index (PASI) ≥12.\n* Have ≥10% body surface area (BSA) involvement.\n* Have obesity, body mass index of ≥30 kilograms per meter squared (BMI ≥30 kg/m²) or overweight (BMI ≥27 to <30 kg/m²) in the presence of at least 1 of these weight-related comorbid conditions (hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or T2DM).\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "Medical Conditions\n\n* Have Type 1 Diabetes Mellitus (T1DM).\n* Have insulin-treated Type 2 Diabetes Mellitus (T2DM).\n* Have a prior or planned surgical treatment for obesity.\n* Have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia (MEN) syndrome type 2.\n* Have active, or a history of inflammatory bowel disease (Crohn's or ulcerative colitis).\n* Have a diagnosis or history of malignant disease within the 5 years prior to randomization, with the following exceptions:\n\n  * basal cell or squamous epithelial carcinomas of the skin that have been resected, with no evidence of metastatic disease for 3 years.\n  * cervical carcinoma in situ, with no evidence of recurrence within the 5 years prior to randomization.\n* Have serious disorder or illness other than PsO.\n* Have a history of chronic or acute pancreatitis.\n* Have any prior use of ixekizumab or tirzepatide.\n* Have a previous failure or intolerance to an interleukin 17 inhibitor (IL-17i) or glucagon-like peptide 1 (GLP-1) receptor agonists.",
    "miscellaneous_criteria": ""
}